Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

The goal of this study is to bring together the power of 1) whole exome sequencing, 2) homozygosity mapping in consanguineous families, and 3) transcriptional analysis in brain tissue to identify genetic causes of autism spectrum disorders (ASD).

Authorized Access
Publicly Available Data (Public ftp)
Molecular Data
TypeSourcePlatformNumber of Oligos/SNPsSNP Batch IdComment
Whole Exome Sequencing Illumina Genome Analyzer II N/A N/A
Whole Exome Sequencing Illumina HiSeq 2000 N/A N/A
Exome Capture Agilent SureSelect DNA Capture Array N/A N/A version 2
Study History

Version 1 of this study included whole exome sequencing data from probands and affected and unaffected family members from consanguineous and non-consanguineous families. Version 2 adds single-nucleus RNA-sequencing of post-mortem frontal cortex and cerebellum samples from individuals diagnosed with Fragile X-associated tremor/ataxia syndrome (FXTAS)

Selected Publications
Diseases/Traits Related to Study (MeSH terms)
Links to Related Genes
Links to Related Resources
Authorized Data Access Requests
Study Attribution
  • Principal Investigator
    • Christopher A. Walsh, PhD. Children's Hospital Corporation, Boston, MA, USA.
  • Funding Sources
    • RC2MH89952. National Institutes of Health, Bethesda, MD, USA.
    • R01MH083565. National Institutes of Health, Bethesda, MD, USA.
    • 178093. Simons Foundation, New York, NY, USA.
  • Funding Source
    • SF09. Simons Foundation, New York, NY, USA.
    • Hock E. Tan and K. Lisa Yang Center for Autism Research at Harvard University. Harvard Medical School, Boston, MA, USA.